HOME >> BIOLOGY >> NEWS
The next generation of scientists recognized at Johns Hopkins

The best of the best. The cream of the crop. Clichs may accurately describe the winners of this year's Young Investigators' Day awards at The Johns Hopkins University School of Medicine, but their work is anything but run of the mill.

Now in its 25th year, Young Investigators' Day recognizes the substantial contributions of all graduate school and medical students, postdoctoral fellows and medical residents and fellows throughout the school of medicine and hospital by rewarding the advances of some of Hopkins' most talented researchers in training.

This year's winning projects have brought a new anti-cancer drug to clinical trial, shown a common diagnostic observation not to be diagnostic at all and turned more than one scientific field on its head. The award recipients will present their study results and accept their awards April 11, beginning at 4 p.m. in Mountcastle Auditorium in the medical school's Preclinical Teaching Building.

"Young investigators are the heart and soul of the research enterprise," says Paul Talalay, M.D., a driving force in the creation of Young Investigators' Day back in 1978 and a continuing supporter. "Each year we take part in an extraordinary intellectual feast, really, in which our young investigators tell the larger Hopkins community about their discoveries. So many wonderful new ideas are presented, and a sense of happy excitement surrounds it."

The results of more than a few of the recognized projects have been or are about to be published in leading journals such as Cell, Science, Nature, The Lancet and The New England Journal of Medicine. But while publication in such journals validates the efforts of a budding scientist or research physician, recognition within Hopkins -- not to mention the award checks -- can be an important boost for young investigators.

"Having my work accepted for publication is a great feeling, but receiving recognition from people I know and have a great deal
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
9-Apr-2002


Page: 1 2 3

Related biology news :

1. Phase II trials of second-generation antisense cancer drug planned following successful early study
2. Disruption of protein-folding causes neurodegeneration, mental retardation
3. Double-segment periodicity underlies odd segment generation in centipedes
4. Gene defects found in age-related macular degeneration
5. UNC scientists discover molecular pathway leading to nerve growth and regeneration
6. Two billion vulnerable to floods by 2050; number expected to double or more in two generations
7. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
8. Land Regeneration Network celebrates first year success
9. Regeneration of injured muscle from adult stem cells
10. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
11. Treatment stimulates growth and regeneration of injured adult skeletal muscle

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):
(Date:5/19/2017)... York (PRWEB) , ... May 19, 2017 , ... In ... in treating gait disorders, Biodex Medical Systems, Inc. announces the release of their Gait ... therapy has been joined with a biomedical system to aid in rehabilitating individuals with ...
(Date:5/18/2017)... ... ... Clinical Supplies Management (“CSM”), a Great Point Partners II (“GPP”) portfolio company, today ... doubled in size over the past six months with the acquisition of businesses in ... CSM as Chief Financial Officer. Roger has over 25 years of experience in ...
(Date:5/18/2017)... ... May 17, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, is honored that Jay Crowley ... conference in Brussels, Belgium. , Crowley played a crucial role in the development ...
(Date:5/18/2017)... MA (PRWEB) , ... May 18, 2017 , ... When James Sherley, was notified earlier ... 50 Most Valuable Brands for the Year 2017 by The Silicon Review , he ... been making good progress increasing Asymmetrex’s value, but this recognition by Silicon Valley was particularly ...
Breaking Biology Technology:
Cached News: